Pfizer has secured regular approval from the US Food and Drug Administration (FDA) for its Xalkori (crizotinib) capsules to treat patients with metastatic ALK-positive non-small cell lung cancer (NSCLC). The approval was based on ...
US-based Sagent Pharmaceuticals has introduced an antineoplastic agent ' Doxorubicin Hydrochloride Injection' in three vial presentations. The injection has been used to produce regression in disseminated neoplastic conditions like acute ...
Boehringer Ingelheim has submitted a marketing authorisation application to the European Medicines Agency (EMA) for the approval of its oral triple angiokinase inhibitor nintedanib. Nintedanib to be used in combination with docetaxel is ...
Tags: Boehringer Ingelheim, Lung Cancer
TriQuint Semiconductor Inc of Hillsboro, OR, USA has announced the release of new gallium nitride (GaN) transistors that offer what is claimed to be superior gain, thermal management and efficiency for commercial and defense RF amplifier ...
Tags: TriQuint, Optical Modulator
US-based clinical stage biopharmaceutical firm Heat Biologics has filed an investigational new drug application (NDA) with the US Food and Drug Administration (FDA) for its second product candidate, HS-410, which will be evaluated in ...
RF front-end component maker and foundry services provider TriQuint Semiconductor Inc of Hillsboro, OR, USA has introduced its first integrated power amplifier solution for small-cell and active antenna base-stations, dramatically reducing ...
Tags: TriQuint, Small-Cell Power
US-based biopharmaceutical company NovaRx will present the results from the Phase III trial of Lucanix (belagenpumatucel-L) post-frontline maintenance therapy in non-small cell lung cancer at the European Society for Medical Oncology (ESMO) ...
Tags: Novarx, Therapeutic Vaccine Trial
Cell Signaling Technology has presented a specific HER3 rabbit monoclonal antibody (mAb) for researchers studying HER2-mediated breast, lung and ovarian tumors. The company has introduced this product with the recent need for HER3 in HER2 ...
Many door and window sensors, motion detectors and keypads that are part of security systems used in millions of homes and businesses can be bypassed by using relatively simple techniques, according to researchers from security consultancy ...
Tags: Office Security Systems
Alcatel-Lucent and Qualcomm Technologies Inc. plan to develop small cell base stations that enhance 3G, 4G and Wi-Fi networks to improve wireless connectivity in residential and enterprise environments. These next-gen small cells would ...
Tags: Consumer Electronics, Electronics
Specialty pharmaceutical company Sagent Pharmaceuticals has introduced an antineoplastic agent, Docetaxel Injection Concentrate, in three preservative-free vial presentations. Designed to help reduce medication errors, the product ...
Tags: Sagent, Medicine errors
Switzerland-based Roche has introduced new Progastrin-releasing peptide (ProGRP) test, Elecsys ProGRP, for precise differentiation of small cell (SCLC) and non-small cell (NSCLC) lung cancer and diagnosis of early-stage SCLC. Used with ...
Tags: Lung Cancer, Peptide Test
The US Food and Drug Administration (FDA) has cleared Boehringer Ingelheim's tyrosine kinase inhibitor Gilotrif (afatinib) as a new medication for patients with late stage (metastatic) non-small cell lung cancer (NSCLC). The approval also ...
Tags: FDA, Lung Cancer Therapy, Medicine
GaAs-based broadband wireless and wireline communications component maker Anadigics Inc of Warren,NJ,USA has introduced two new power amplifiers(PAs)optimized for WCDMA,HSPA,and LTE small-cell applications,including ...
Tags: Anadigics PAs, power amplifiers, infrastructure power amplifiers
Nitronex LLC of Durham, NC, USA, which designs and makes gallium nitride on silicon (GaN-on-Si)-based RF power transistors for the defense, communications, broadband and industrial & scientific markets, has developed a family of products ...